Healthcare & Pharmaceuticals · East India Pharmaceutical Works Limited Unlisted / Pre-IPO Share Price
As of 28 Sept 2026, the East India Pharmaceutical Works Limited unlisted share price is ₹79 per share. East India Pharmaceutical Works Limited is an unlisted / pre-IPO company — not listed on NSE or BSE. ISIN: INE254X01017.
Key figures for East India Pharmaceutical Works Limited
East India Pharmaceutical Works Limited (EIPWL) is one of India's oldest pharmaceutical companies, established in 1936 and headquartered in Kolkata, West Bengal. With over eight decades of experience, EIPWL has built a strong presence in the Indian pharmaceutical industry, focusing on manufacturing and marketing a diverse range of healthcare products.
East India Pharmaceutical Works Limited shares are unlisted, so they are bought off-market through a SEBI-registered intermediary rather than on the NSE or BSE. With Safal Capital the process is simple:
No. East India Pharmaceutical Works Limited is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE and there is no live “East India Pharmaceutical Works Limitedshare price NSE”. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
East India Pharmaceutical Works Limited has not announced a confirmed IPO date. Investors buy unlisted shares ahead of a potential listing for pre-IPO upside, but a listing is never guaranteed and timelines can change. The ISIN for East India Pharmaceutical Works Limited is INE254X01017. Contact our desk for the latest status and a live quote before you invest.
Safal Capital tracks East India Pharmaceutical Works Limited for pricing updates, liquidity context, and investor suitability.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
Latest source-linked updates that may be relevant to this company.
Solid Listing On Cards? SRIT India IPO GMP Signals 23% Gains As Issue Gets Fully Subscribed NDTV Profit
Srit India IPO fully bid on day 1 Business Standard
As of 28 Sept 2026, the East India Pharmaceutical Works Limited unlisted (pre-IPO) share price is ₹79 per share on Safal Capital. Unlisted share prices move with demand, supply and deal size, so contact our desk for a live, deal-specific quote before you transact.
You buy East India Pharmaceutical Works Limited unlisted shares off-market through a SEBI-registered intermediary. With Safal Capital: (1) share your requirement and quantity, (2) we confirm the live price and availability, (3) you complete KYC, (4) transfer funds, and (5) the shares are credited to your demat account, usually within T+1 to T+2 working days.
No. East India Pharmaceutical Works Limited is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
East India Pharmaceutical Works Limited has not announced a confirmed IPO date. Unlisted shares are often bought before a potential listing in the hope of pre-IPO gains, but a listing is never guaranteed and timelines can change. Speak to our advisors for the latest status on East India Pharmaceutical Works Limited.
The ISIN for East India Pharmaceutical Works Limited unlisted shares is INE254X01017. You will need this ISIN when the shares are credited to your demat account.
East India Pharmaceutical Works Limited unlisted shares have a face value of ₹10 and a typical minimum lot of 250 shares. Minimum quantities can vary with availability and deal size — our desk will confirm the current lot before you invest.
Unlisted share prices are not set by an exchange. The East India Pharmaceutical Works Limited price reflects recent off-market deals, buyer/seller demand, the company's financials and expectations around a future IPO. Because it is over-the-counter, always confirm a live quote before transacting.
Unlisted shares like East India Pharmaceutical Works Limited can offer pre-IPO upside but carry higher risk and lower liquidity than listed stocks, and there is no guaranteed exit. Invest only after reviewing the company's fundamentals and your risk profile — Safal Capital's SEBI-registered advisors can help you assess East India Pharmaceutical Works Limited.
India's IPO pipeline hits Rs 3.86 lakh crore. What's driving the rush India Today
